Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
in response to
by
posted on
Dec 05, 2017 02:42PM
This is unreal. The list of potential disease targets keeps getting bigger and bigger.
I'm hoping we're going to see a nice drop in short interest, I already have a sub-text for my next blog post in mind if the number of borrowed shares shows another drop.....something along the lines of "Short sellers running for the hills, and with good reason".
It was only back in June that the number spiked up to near 850K and as of the last update it was down to 172,200
I know there are lots of companies that would be all over news like this, trumpetting it to the market to drum up interest. I don't mind that Resverlogix isn't doing this, the fact they're not strengthens my opinion that the company is doing everything it can to keep things as quiet as possible.